叔丁氧基乙酸 | 13211-32-0

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 叔丁氧基乙酸
• 中文别名: 2-特丁氧基乙酸
• 英文名称: tert-butoxyacetic acid
• 英文别名: 2-(tert-butoxy)acetic acid；tert.-Butoxy-essigsaeure；tert-Butyloxy-essigsaeure；t-butoxyacetic acid；2-t-butyloxyacetic acid；(1,1-dimethylethoxy)acetic acid；2-[(2-methylpropan-2-yl)oxy]acetic acid
• CAS: 13211-32-0
• 化学式: C₆H₁₂O₃
• mdl: MFCD03452738
• 分子量: 132.159
• InChiKey: HQLILHPGWSURBT-UHFFFAOYSA-N

物化性质

• 熔点：
  -5 °C
• 沸点：
  104-106 °C(Press: 12 Torr)
• 密度：
  1.027±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2918990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: tert-Butoxy acetic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H335: May cause respiratory irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: tert-Butoxy acetic acid
CAS number: 13211-32-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H12O3
Molecular weight: 132.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  叔丁氧基乙酸 在 silver nitrate 作用下， 以 甲醇 、 水 、 乙酸乙酯 、 三氟乙酸 为溶剂， 生成 methyl 5-(tert-butoxymethyl)-6-methoxypyridazine-3-carboxylate
  参考文献：
  名称：

  NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

  摘要：

  化合物的化学式I： 是HIV反转录酶抑制剂，其中R 1 ，R 2 ，E，L，M和Z在此处定义。化合物I的化合物及其药学上可接受的盐在抑制HIV反转录酶，预防和治疗HIV感染以及预防，延迟发病或进展和治疗艾滋病方面是有用的。这些化合物及其盐可作为药物组合物中的成分，可选择地与其他抗病毒药物，免疫调节剂，抗生素或疫苗结合使用。

  公开号：

  US20140100231A1
• 作为产物：
  描述：

  过氧化乙酸叔丁酯 在 potassium tert-butylate 作用下， 以 N,N-二甲基甲酰胺 、 正戊烷 为溶剂， 反应 4.0h， 以86%的产率得到叔丁氧基乙酸
  参考文献：
  名称：

  Peroxy esters. 8. Base-catalyzed rearrangement of peroxy esters: formation of alkoxyacetic acid derivatives

  摘要：

  DOI：

  10.1021/jo00169a016

文献信息

• 1-carboalkoxyalkyl-3-alkoxy-4-(2'-carboxyphenyl)-azet-2-ones as plant
  申请人：Chevron Research Company

  公开号：US04846873A1

  公开（公告）日：1989-07-11

  Compounds of the formula: ##STR1## wherein R.sup.1 is lower alkyl of 1 to 6 carbon atoms lower alkenyl of 2 to 6 carbon atoms or benzyl; R.sup.2 is lower alkoxy of 1 to 6 carbon atoms, benzyloxy or the group ##STR2## where R.sup.4 is lower alkoxy of 1 to 4 carbon atoms; and R.sup.3 is hydrogen, lower alkyl of 1 to 6 carbon atoms, lower alkyl of 1 to 6 carbon atoms substituted with 1 to 3 trihalomethyl groups, lower haloalkyl of 1 to 6 carbon atoms substituted with 1 to 6 halogen atoms, lower alkenyl of 2 to 6 carbon atoms, arylalkyl of 7 to 12 carbon atoms, lower alkoxyalkyl of 2 to 6 carbon atoms, lower alkylthioalkyl of 2 to 6 carbon atoms, or lower cycloalkyl of 3 to 8 carbon atoms are active as plant growth regulators. Certain of these compounds also show activity as selective herbicides.

  该公式化合物为：##STR1## 其中R.sup.1为1至6个碳原子的低烷基、2至6个碳原子的低烯基或苄基；R.sup.2为1至6个碳原子的低烷氧基、苄氧基或基团##STR2## 其中R.sup.4为1至4个碳原子的低烷氧基；R.sup.3为氢、1至6个碳原子的低烷基、1至6个碳原子的低烷基，其上取代有1至3个三卤甲基基团，1至6个卤原子取代的1至6个碳原子的低卤代烷基，2至6个碳原子的低烯基，7至12个碳原子的芳基烷基，2至6个碳原子的低烷氧基烷基，2至6个碳原子的低烷硫基烷基，或3至8个碳原子的低环烷基，对植物生长调节剂具有活性。其中某些化合物也表现出选择性除草剂的活性。
• ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
  申请人：AbbVie Inc.

  公开号：US20170355769A1

  公开（公告）日：2017-12-14

  The invention relates to B7 homology 3 protein (B7-H3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

  这项发明涉及B7同源物3蛋白（B7-H3）抗体和抗体药物结合物（ADCs），包括使用所述抗体和ADCs的组合物和方法。
• [EN] ANALGESIC COMPOUNDS<br/>[FR] COMPOSÉS ANALGÉSIQUES
  申请人：ZENO ROYALTIES & MILESTONES LLC

  公开号：WO2018213140A1

  公开（公告）日：2018-11-22

  Disclosed herein are compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It), methods of synthesizing compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It), and methods of using compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It) as an analgesic.

  本文披露了化合物的化学式（Ia）、（Ib）、（Ic）、（Id）、（Ie）、（If）、（Ig）、（Ih）、（Ik）、（Im）、（In）、（Io）、（Ip）、（Iq）、（Ir）、（Is）和（It），合成化合物的方法的化学式（Ia）、（Ib）、（Ic）、（Id）、（Ie）、（If）、（Ig）、（Ih）、（Ik）、（Im）、（In）、（Io）、（Ip）、（Iq）、（Ir）、（Is）和（It），以及使用化合物的方法的化学式（Ia）、（Ib）、（Ic）、（Id）、（Ie）、（If）、（Ig）、（Ih）、（Ik）、（Im）、（In）、（Io）、（Ip）、（Iq）、（Ir）、（Is）和（It）作为镇痛剂。
• [EN] PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] DÉRIVÉS D'ACIDE PYRIDIN-3-YLE ACÉTIQUE UTILISÉS EN TANT QU'INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
  申请人：VIIV HEALTHCARE UK NO 5 LTD

  公开号：WO2018127800A1

  公开（公告）日：2018-07-12

  Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS. (I)

  公开了公式I的化合物，包括药用可接受的盐、包含这些化合物的药物组合物、制备这些化合物的方法，以及它们在抑制HIV整合酶和治疗HIV或艾滋病感染者中的用途。
• [EN] TRICYCLIC MODULATORS OF TNF SIGNALING<br/>[FR] MODULATEURS TRICYCLIQUES DE LA SIGNALISATION DU TNF
  申请人：ABBVIE INC

  公开号：WO2016168641A1

  公开（公告）日：2016-10-20

  The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.

  这项发明提供了三环杂环化合物，其药用盐、前药、生物活性代谢物、立体异构体和同分异构体，其中变量在此处定义。该发明的化合物可能对治疗免疫和肿瘤疾病有用。

表征谱图